Latest Institutional Purchases of Salarius Pharmaceuticals, Inc. (SLRX)
This list provides information on the latest institutional transactions involving Salarius Pharmaceuticals, Inc. (SLRX) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
96.2K+ 17.88% |
$16.4K - $3.98M
|
634K
$951K
|
|
|
Nov 14, 2022
Q3 2022
|
Horizon Kinetics Asset Management LLC
|
BUY
|
- |
20K+ 50.0% |
$3.4K - $827K
|
60K
$90K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
2+ 0.13% |
$0.34 - $82.7
|
1.5K
$2.25K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
| Q2 2022 | |||||||
|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
42.7K+ 108.15% |
$6.83K - $17.9K
|
82.2K
$123K
|
|
|
Aug 02, 2022
Q2 2022
|
E Rn Financial, LLC
|
BUY
|
- |
32.1KNew |
$5.13K - $13.5K
|
32.1K
$48.1K
|
|
|
Aug 10, 2022
Q2 2022
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
26.6KNew |
$4.25K - $11.2K
|
26.6K
$39.8K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
23K+ 5.9% |
$3.68K - $9.67K
|
413K
$620K
|
|
| Q1 2022 | |||||||
|
May 12, 2022
Q1 2022
|
Cambridge Investment Research Advisors, Inc.
|
BUY
|
- |
21.3KNew |
$7.24K - $11.5K
|
21.3K
$31.9K
|
|
|
May 11, 2022
Q1 2022
|
Financial Advocates Investment Management
Olympia, WA |
BUY
|
- |
11.5KNew |
$3.9K - $6.19K
|
11.5K
$17.2K
|
|
|
May 16, 2022
Q1 2022
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
1KNew |
$340 - $540
|
1K
$1.5K
|
|
| Q2 2021 | |||||||
|
Aug 16, 2021
Q2 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
143KNew |
$145K - $217K
|
143K
$214K
|
|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
39.8K+ 29.58% |
$40.6K - $60.5K
|
174K
$262K
|
|